Table 1. Conflicts of Interest Disclosures From Speakers.

Variable	No. (%) of Speakers (N = 129)
Reimbursed for travel	89 (69.0)
Represented an organization that has received money from pharmaceutical drug company	13 (10.1)
Was or has been a consultant to the pharmaceutical drug company	13 (10.1)
Has received a grant from the pharmaceutical drug company	5 (3.8)
Donated money to research for the drug in question	4 (3.1)
Was an investigator in the drug’s trial	3 (2.3)
Owns stock in pharmaceutical drug company	1 (0.7)
Pharmaceutical representative who wants to represent the drug	1 (0.7)